BridgeBio Plans to Present Acoramidis Data at AHA Meeting
BridgeBio plans to present new data on heart failure events related to acoramidis at the AHA meeting.
Related stories
Dow Falls While Nasdaq Rises in Election Day Trading
Tuesday’s session reversed the previous pattern, with the Dow lower and the Nasdaq higher.
M impact | EQUITY | Nov 03, 2026, 04:32 PM UTC
Supermarket Income REIT Raises £60 Million in Share Issue
Supermarket Income REIT raised gross proceeds of £60 million in an issue.
M impact | EQUITY | Nov 03, 2026, 04:31 PM UTC
Centurion Shares to Resume Trading November 5
Trading in Centurion Minerals’ common shares is scheduled to resume on the TSX Venture Exchange at the market open on November 5, 2026. The company also provided an update on its o
M impact | EQUITY | Nov 03, 2026, 04:31 PM UTC
Euro Stoxx index falls 0.35%
Euro zone blue chips are down 0.37%.
M impact | EQUITY | Nov 03, 2026, 04:31 PM UTC
FTSE 100 falls 1.03%; DAX drops 0.31%
M impact | EQUITY | Nov 03, 2026, 04:31 PM UTC
France's CAC 40 Falls 0.22%; Spain's IBEX Drops 0.72%
M impact | EQUITY | Nov 03, 2026, 04:31 PM UTC